OPKO Health, Inc. (OPK) key performance indicators and operating metrics (7 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Revenue from Products | 38M | FY2026-Q1 |
| Diagnostics Revenue from Services | 72.2M | FY2026-Q1 |
| Rayaldee Revenue | 6.3M | FY2026-Q1 |
| Loss per Share, Basic and Diluted | -0.07 USD_per_share | FY2026-Q1 |
| Revenue from Transfer of Intellectual Property and Other | 14M | FY2026-Q1 |
| Revenue from Products (Pharmaceuticals) | 37.7M | FY2025-Q3 |
| Revenue from Services | 101.1M | FY2025-Q2 |
Back to OPK overview · OPK earnings · OPK holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.